FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES. CAHIERS MAGELLANES-NS, [S. l.], v. 6, n. 2, p. 7092–7101, 2024. Disponível em: http://cahiersmagellanes.com/index.php/CMN/article/view/1040.. Acesso em: 14 jun. 2025.